跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DEXMEDETOMIDINE HYDROCHLORIDE INJECTION - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
DEXMEDETOMIDINE HYDROCHLORIDE INJECTION
Authorized
STANDARD
DEXMEDETOMIDINE HYDROCHLORIDE INJECTION
Juno Pharmaceuticals Corp.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
799d7cd354e5fd86
Company
Juno Pharmaceuticals Corp.
Type
Standard
Approval Details
Approval Id
799d7cd354e5fd86
Drug Approval Canada Name
DEXMEDETOMIDINE HYDROCHLORIDE INJECTION
Product Name
DEXMEDETOMIDINE HYDROCHLORIDE INJECTION
Status
Marketed
Status Date
2020-09-30
Original Market Date
2020-09-30
Din
02487373
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
28:24.92
Atc Original
N05CM18 DEXMEDETOMIDINE
Atc Name
n 05 cm 18
Aig Number
0152679004
Company Name
Juno Pharmaceuticals Corp.
Company Address
402, 2233 Argentia Road, Mississauga, Ontario, Canada, L5N 2X7
Active Ingredients
DEXMEDETOMIDINE (DEXMEDETOMIDINE HYDROCHLORIDE)
400 MCG / 100 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
799d7cd354e5fd86
Type
Standard
Back to Health Canada Approvals